Security key
07725L102
BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)
CUSIP: 07725L102
Q1 2018 13F Holders as of 31 Mar 2018
- Security type / class
- Equity / Ordinary Shares, par value $0.0001 per share
- Total 13F shares
- 36,449,398
- Total 13F value
- $6,123,436,880
- Share change
- +8,886,183
- Put/Call ratio
- 19%
- SEC-reported price per share
- $168.00
- Number of holders
- 122
- Value change
- +$1,501,911,684
- Number of buys
- 81
- Number of sells
- 48
- Shares outstanding
- 1,448,910,175
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2018
Institutions
122
Top holders
10
ONC full security history
Ownership snapshot
Full 13F holder table
BeOne Medicines Ltd. SEC filings
BeOne Medicines Ltd. company facts
BeOne Medicines Ltd. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2017
13F
Lead comparable stake: 0.31%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 0.31%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
0.31%
HILLHOUSE INVESTMENT MANAGEMENT, ...
0.27%
BAKER BROS. ADVISORS LP
0.27%
WELLINGTON MANAGEMENT GROUP LLP
0.26%
Temasek Holdings (Private) Ltd
0.09%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
0.31%
|
$440,579,000
4,508,588 shares
|
— | 31 Dec 2017 |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. |
13F
Company
|
0.27%
|
$380,794,000
3,896,782 shares
|
— | 31 Dec 2017 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
0.27%
|
$376,147,000
3,849,231 shares
|
— | 31 Dec 2017 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
0.26%
|
$372,665,000
3,813,606 shares
|
— | 31 Dec 2017 |
| Temasek Holdings (Private) Ltd |
13F
Company
|
0.09%
|
$125,082,000
1,280,000 shares
|
— | 31 Dec 2017 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.07%
|
$101,774,000
1,041,488 shares
|
— | 31 Dec 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
122
Shares
36,449,398
Rows available
122
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2018 vs Q1 2018 Across Filers
Q1 2018 holders
122
Q1 2018 holders
122
Holder diff
0
| Investor | Q1 2018 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q1 2018 value | Q1 2018 value | Value change | Value Chg % |
|---|